Fractyl Health Inc [NASDAQ: GUTS] closed the trading session at $1.01 on 2025-08-06. The day’s price range saw the stock hit a low of $0.825, while the highest price level was $1.05.
The stocks have a year to date performance of -59.76 percent and weekly performance of -44.51 percent. The stock has been moved at -34.20 percent over the last six months. The stock has performed -32.67 percent around the most recent 30 days and changed -32.67 percent over the most recent 3-months.
If compared to the average trading volume of 524.26K shares, GUTS reached to a volume of 8783897 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Fractyl Health Inc [GUTS]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for GUTS shares is $9.33 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on GUTS stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Evercore ISI have made an estimate for Fractyl Health Inc shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on February 28, 2024. While these analysts kept the previous recommendation, Morgan Stanley raised their target price to Overweight. The new note on the price target was released on February 27, 2024, representing the official price target for Fractyl Health Inc stock. Previously, the target price had yet another raise to $26, while BofA Securities analysts kept a Buy rating on GUTS stock.
The Price to Book ratio for the last quarter was 7.75, with the Price to Cash per share for the same quarter was set at 0.86.
GUTS stock trade performance evaluation
Fractyl Health Inc [GUTS] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -44.51. With this latest performance, GUTS shares dropped by -32.67% in over the last four-week period, additionally sinking by -34.20% over the last 6 months – not to mention a drop of -50.97% in the past year of trading.
Fractyl Health Inc [GUTS]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Fractyl Health Inc [GUTS] shares currently have an operating margin of -161246.67% and a Gross Margin at -1475.00%. Fractyl Health Inc’s Net Margin is presently recorded at -148511.67%.
Fractyl Health Inc (GUTS) Capital Structure & Debt Analysis
According to recent financial data for Fractyl Health Inc. ( GUTS), the Return on Equity (ROE) stands at -196.81%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -72.28%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Fractyl Health Inc’s Return on Invested Capital (ROIC) is -141.87%, showcasing its effectiveness in deploying capital for earnings.
Fractyl Health Inc (GUTS) Efficiency & Liquidity Metrics
Based on Fractyl Health Inc’s (GUTS) latest financial statements, the Debt-to-Equity Ratio is 9.63%, indicating its reliance on debt financing relative to shareholder equity.
Fractyl Health Inc (GUTS) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Fractyl Health Inc. (GUTS) effectively leverages its workforce, generating an average of -$832803.74 per employee. The company’s liquidity position is robust, with a Current Ratio of 2.50% and a Quick Ratio of 2.50%, indicating strong ability to cover short-term liabilities.
Earnings per share (EPS) analysis for Fractyl Health Inc [GUTS] stock
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for GUTS. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Fractyl Health Inc go to 7.56%.
Fractyl Health Inc [GUTS]: Institutional Ownership
There are presently around $82.48%, or 86.67%% of GUTS stock, in the hands of institutional investors. The top three institutional holders of GUTS stocks are: DEER MANAGEMENT CO. LLC with ownership of 4.77 million shares, which is approximately 9.9603%. HCC MANAGER LLC, holding 4.67 million shares of the stock with an approximate value of $$34.59 million in GUTS stocks shares; and HCC MANAGER LLC, currently with $$18.17 million in GUTS stock with ownership which is approximately 8.8825%.
